First-in-class approach to targeting mitochondrial DNA polymerase (POLG) with disease modifying potential across mitochondrial DNA depletion syndromes ...
However, around 20% to 30% of patients with nocardiosis have no known pre-existing conditions, so the infection doesn't ...